Tiagabine in the treatment of epilepsy – a case report Case report
Main Article Content
Abstract
Add-on therapy with tiagabine can be effective in selected cases of focal seizures. Tiagabine in combination with lacosamide seems to be effective in patients with seizures resistant to other antiepileptic drugs. The cases presented proves this. The limiting effects of lacosamide and tiagabine may be side effects of both substances. But they occur temporarily and are most intensified at the beginning of treatment. Slowly increasing the doses of each drug seizures helps patients to tolerate the therapy.
Article Details
How to Cite
Bogucki, P. (2018). Tiagabine in the treatment of epilepsy – a case report. Medycyna Faktow (J EBM), 11(4(41), 310-312. https://doi.org/10.24292/01.MF.0418.9
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Süße M., Hamann L., Flöel A., von Podewils F.: Nonlesional late-onset epilepsy: Semiology, EEG, cerebrospinal fluid, and seizure outcome characteristics. Epilepsy Behav. 2018. DOI: 10.1016/j.yebeh.2018.05.043.
2. Laxer K.D., Trinka E., Hirsch L.J. et al.: The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014; 37: 59-70.
3. Baker M.D., Abou-Khalil B.W., Arain A. et al.: Lacosamide efficacy and tolerability in clinical practice – Post marketing analysis from a single dedicated epilepsy center. Clin. Neurol. Neurosurg. 2018; 171: 179-183.
4. Pulman J., Jette N., Dykeman J. et al.: Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst. Rev. 2014; (2): CD001417. DOI: 10.1002/14651858.CD001417.pub3.
2. Laxer K.D., Trinka E., Hirsch L.J. et al.: The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014; 37: 59-70.
3. Baker M.D., Abou-Khalil B.W., Arain A. et al.: Lacosamide efficacy and tolerability in clinical practice – Post marketing analysis from a single dedicated epilepsy center. Clin. Neurol. Neurosurg. 2018; 171: 179-183.
4. Pulman J., Jette N., Dykeman J. et al.: Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst. Rev. 2014; (2): CD001417. DOI: 10.1002/14651858.CD001417.pub3.